In a surprising turn of events, the kratom industry is now actively seeking regulation from the U.S. Food and Drug Administration (FDA).
While the tropical tree native to Southeast Asia has often been the subject of FDA warnings, the industry believes that regulation could bring much-needed clarity. The American Kratom Association (AKA) has issued a Consumer Advisory urging the FDA to publish product manufacturing standards for kratom.
The AKA’s call for action comes in the wake of recent wrongful death jury awards in Florida, which the industry group attributes to the FDA’s failure to regulate the kratom marketplace.
Mac Haddow, the AKA’s Senior Fellow on Public Policy, emphasized the need for congressional action to compel the FDA to develop and implement standards for the manufacturing and marketing of kratom products.
